Jaime Alberto Cabal, president of the trade union (Fenalco), asked to study the inclusion of additional resources intended for the payment of debts and pending payments to pharmaceutical managers, who are in charge of distribution of medicines and supplies, which are not included in the Plan. Benefits.
“This request is due to the fact that, until now, the unionized managers of Fenalco have an outstanding balance of more than one billion pesos,” said the letter sent to Guillermo Alfonso Jaramillo, Minister of Health and Social Protection, and Ricardo Bonilla, Minister of Finance and Public Credit.
Although the president of the union clarified that the Government pays, it covers only 80% of the value of the services provided, which creates a deficit of 20%, which increases the amount pending payment.
In addition, the lack of budget adjustments for 2022 and 2023 has created a gap, making resources insufficient to cover the costs incurred in the distribution of medicines and equipment. in health, which the managers have effectively done for the benefit of millions of Colombians.
“Also at this time, the transfers for the Maximum Budgets (PM) corresponding to the months of July and August are pending, which means that currently pharmaceutical managers are directly financing and benefiting from the distribution of drugs and supplies for health. Colombian patients, who under no circumstances can stop their medical treatments,” added the spokesperson of the traders.
Finally, Cabal Sanclemente made an urgent call to guarantee the liquidity of the General Health Social Security System (SGSSS), which will allow the proper and timely operation of pharmaceutical managers, where he also requested that they be included in the work, like other unions in the sector, considering the importance of this segment, which delivers medicines throughout the national territory.
Likewise, he requested joint work areas with the Ministry of Health, which would allow for quick and effective solutions to be established for this difficult situation.